Skip to main content
Quest Diagnostics

Refractory Antimelanoma Differentiation-Associated Gene 5 Antibody Negative Ulcerative Dermatomyositis Responsive to Mycophenolate Mofetil

Refractory Antimelanoma Differentiation-Associated Gene 5 Antibody Negative Ulcerative Dermatomyositis Responsive to Mycophenolate Mofetil

Authors: Ozer S, Farabi B, Kann R, Atak MF, Shulman K, Marmon S

Citation: JAAD Case Rep. 2024 May 21;50:1-3. doi: 10.1016/j.jdcr.2024.05.017.

Specialties: Dermatology, Immunology, Autoimmune disease

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath Diagnostics, a subsidiary of Quest Diagnostics.

Related content

Publication
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay
Conference Presentation
The Prevalence and Clinical Relevance of the DFS Immunofluorescent Staining Pattern in a Large ANA-Positive Cohort
Test FAQ
Tests for Autoimmune Diseases
On-Demand Webinar
Mutated Citrullinated Vimentin Antibody as an Alternative Marker for RA

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.